However, blocking GLUT-1 has been associated with severe adverse effects, including seizures, as seen in GlLUT-1 deficiency syndrome (GLUT-1-DS), rendering these agents unsuitable for PTSD or CVD [241]. This evidence concerns the gene SLC2A1 and post-traumatic stress disorder.